Phase Angle as Surrogate Marker of Muscle Weakness in Kidney Transplant Candidates Referred to Prehabilitation.
Ester MarcoMaría José Pérez-SáezElena Muñoz-RedondoYulibeth G CurbeloCindry Ramírez-FuentesDelky Meza-ValderramaCarolina Acuña-PardoMª Dolors MunsOlga Vázquez-IbarBetty Odette ChamounAnna Faura-VendrellAnna Bach-PascualMarta CrespoJulio Pascualnull nullPublished in: Nutrients (2024)
Phase angle (PhA), a marker of nutritional status obtained by bioelectrical impedance analysis (BIA), is associated with the integrity of cell membranes. Damage to muscle fiber membranes can impact muscle strength, which is related to adverse outcomes in adults with advanced chronic kidney disease (CKD). The main objective of this study was to determine the usefulness of the PhA in identifying muscle weakness in candidates for kidney transplants (KTs). Secondly, it aimed to examine the associations of PhA with other parameters of body composition, exercise performance, and muscle structure. Sensitivity, specificity, and area under the receiver operating characteristics curve were used to evaluate the PhA (index test) as a biomarker of muscle weakness. Muscle strength was estimated with maximal voluntary isometric contraction of the quadriceps (MVCI-Q) of the dominant side. Muscle weakness was defined as MVIC-Q < 40% of body weight. A total of 119 patients were evaluated (mean age 63.7 years, 75.6% men). A phase angle cut-off of 5.1° was identified to classify men with a higher likelihood of having low muscle strength in upper limbs (MVIC-Q 40% of their body weight). Male KT candidates with PhA < 5.1° had poorer exercise capacity, lower muscle strength, less muscle mass, and smaller muscle size. A PhA < 5.1° was significantly associated with an eight-fold higher muscle weakness risk (OR = 8.2, 95%CI 2.3-29.2) in a binary regression model adjusted by age, frailty, and hydration status. Remarkably, PhA is an easily obtainable objective parameter in CKD patients, requiring no volitional effort from the individual. The associations of PhA with aerobic capacity, physical activity, muscle mass, and muscle size underscore its clinical relevance and potential utility in the comprehensive evaluation of these patients.
Keyphrases
- chronic kidney disease
- end stage renal disease
- skeletal muscle
- body composition
- body weight
- physical activity
- ejection fraction
- resistance training
- newly diagnosed
- prognostic factors
- stem cells
- single cell
- magnetic resonance
- high resolution
- bone marrow
- depressive symptoms
- body mass index
- bone mineral density
- computed tomography
- cell therapy
- postmenopausal women
- ionic liquid
- myasthenia gravis
- anterior cruciate ligament